1. Clinical Actionability Enhanced through Deep Targeted Sequencing of Solid Tumors. (6th January 2020) Authors: Chen, Ken; Meric-Bernstam, Funda; Zhao, Hao; Zhang, Qingxiu; Ezzeddine, Nader; Tang, Lin-ya; Qi, Yuan; Mao, Yong; Chen, Tenghui; Chong, Zechen; Zhou, Wanding; Zheng, Xiaofeng; Johnson, Amber; Aldape, Kenneth D; Routbort, Mark J; Luthra, Rajyalakshmi; Kopetz, Scott; Davies, Michael A; de Groot, Jo... Journal: Clinical chemistry Issue: Volume 61:Number 3(2015) Page Start: 544 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. CODEL: phase III study of RT, RT + TMZ, or TMZ for newly diagnosed 1p/19q codeleted oligodendroglioma. Analysis from the initial study design. Issue 3 (17th July 2020) Authors: Jaeckle, Kurt A; Ballman, Karla V; van den Bent, Martin; Giannini, Caterina; Galanis, Evanthia; Brown, Paul D; Jenkins, Robert B; Cairncross, J Gregory; Wick, Wolfgang; Weller, Michael; Aldape, Kenneth D; Dixon, Jesse G; Anderson, S Keith; Cerhan, Jane H; Wefel, Jeffrey S; Klein, Martin; Grossman... Journal: Neuro-oncology Issue: Volume 23:Issue 3(2021) Page Start: 457 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. DNA methylation profiling to predict recurrence risk in meningioma: development and validation of a nomogram to optimize clinical management. Issue 7 (3rd June 2019) Authors: Nassiri, Farshad; Mamatjan, Yasin; Suppiah, Suganth; Badhiwala, Jetan H; Mansouri, Sheila; Karimi, Shirin; Saarela, Olli; Poisson, Laila; Gepfner-Tuma, Irina; Schittenhelm, Jens; Ng, Ho-Keung; Noushmehr, Houtan; Harter, Patrick; Baumgarten, Peter; Weller, Michael; Preusser, Matthias; Herold-Mende... Journal: Neuro-oncology Issue: Volume 21:Issue 7(2019) Page Start: 901 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. DNA methylation-based prognostic subtypes of chordoma tumors in tissue and plasma. Issue 3 (6th October 2021) Authors: Zuccato, Jeffrey A; Patil, Vikas; Mansouri, Sheila; Liu, Jeffrey C; Nassiri, Farshad; Mamatjan, Yasin; Chakravarthy, Ankur; Karimi, Shirin; Almeida, Joao Paulo; Bernat, Anne-Laure; Hasen, Mohammed; Singh, Olivia; Khan, Shahbaz; Kislinger, Thomas; Sinha, Namita; Froelich, Sébastien; Adle-Biassette... Journal: Neuro-oncology Issue: Volume 24:Issue 3(2022) Page Start: 442 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Fibrolamellar carcinoma transcriptomic-based treatment prediction: complete response after nivolumab and ipilimumab. Issue 12 (9th December 2022) Authors: Berger, Raanan; Dinstag, Gal; Tirosh, Omer; Schiff, Eyal; Kleiner, David; Aldape, Kenneth D; Ruppin, Eytan; Beker, Tuvik; Kurzrock, Razelle Journal: Journal for immunotherapy of cancer Issue: Volume 10:Issue 12(2022) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Gli1‐induced deubiquitinase USP48 aids glioblastoma tumorigenesis by stabilizing Gli1. (16th June 2017) Authors: Zhou, Aidong; Lin, Kangyu; Zhang, Sicong; Ma, Li; Xue, Jianfei; Morris, Saint‐Aaron; Aldape, Kenneth D; Huang, Suyun Journal: EMBO reports Issue: Volume 18:Number 8(2017) Page Start: 1318 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Glioblastoma in adults: a Society for Neuro-Oncology (SNO) and European Society of Neuro-Oncology (EANO) consensus review on current management and future directions. Issue 8 (24th April 2020) Authors: Wen, Patrick Y; Weller, Michael; Lee, Eudocia Quant; Alexander, Brian M; Barnholtz-Sloan, Jill S; Barthel, Floris P; Batchelor, Tracy T; Bindra, Ranjit S; Chang, Susan M; Chiocca, E Antonio; Cloughesy, Timothy F; DeGroot, John F; Galanis, Evanthia; Gilbert, Mark R; Hegi, Monika E; Horbinski, Crai... Journal: Neuro-oncology Issue: Volume 22:Issue 8(2020) Page Start: 1073 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. MGMT promoter methylation status testing to guide therapy for glioblastoma: refining the approach based on emerging evidence and current challenges. Issue 2 (5th September 2018) Authors: Mansouri, Alireza; Hachem, Laureen D; Mansouri, Sheila; Nassiri, Farshad; Laperriere, Normand J; Xia, Daniel; Lindeman, Neal I; Wen, Patrick Y; Chakravarti, Arnab; Mehta, Minesh P; Hegi, Monika E; Stupp, Roger; Aldape, Kenneth D; Zadeh, Gelareh Journal: Neuro-oncology Issue: Volume 21:Issue 2(2019) Page Start: 167 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Mutations of FH and IDH may induce gliomagenesis by similar mechanisms. Issue 1 (11th November 2022) Authors: Raghunathan, Aditya; Ida, Cristiane M; Westbroek, Erick M; Gupta, Sounak; Jenkins, Robert B; Giannini, Caterina; Aldape, Kenneth D Journal: Journal of neuropathology and experimental neurology Issue: Volume 82:Issue 1(2023) Page Start: 99 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Sox2: regulation of expression and contribution to brain tumors. (July 2016) Authors: Mansouri, Sheila; Nejad, Romina; Karabork, Merve; Ekinci, Can; Solaroglu, Ihsan; Aldape, Kenneth D; Zadeh, Gelareh Journal: CNS oncology Issue: Volume 5:Number 3(2016) Page Start: 159 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗